SPX4,071.70-4.87 -0.12%
DIA344.74+0.33 0.10%
IXIC11,461.50-20.95 -0.18%

JonesTrading Downgrades Inhibikase Therapeutics to Hold

Benzinga · 11/16/2022 08:08
JonesTrading analyst Soumit Roy downgrades Inhibikase Therapeutics (NASDAQ:IKT) from Buy to Hold.